Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
